BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35003085)

  • 1. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
    Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
    Front Immunol; 2021; 12():769685. PubMed ID: 35003085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
    Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
    Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
    Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
    Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of prognostic models for glycosylation-related subtypes and tumor microenvironment infiltration characteristics in clear cell renal cell cancer.
    Shen C; Zheng B; Chen Z; Zhang W; Chen X; Xu S; Ji J; Fang X; Shi C
    Heliyon; 2024 Mar; 10(6):e27710. PubMed ID: 38515689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
    Yang B; Wang Y; Liu T; Zhang M; Luo T
    Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer.
    Zhang X; Zhao H; Shi X; Jia X; Yang Y
    Aging (Albany NY); 2020 Dec; 12(24):26095-26120. PubMed ID: 33401247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
    Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
    Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
    Li X; Wen D; Li X; Yao C; Chong W; Chen H
    Front Immunol; 2020; 11():1678. PubMed ID: 33013820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
    Wang Z; Niu D
    Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
    Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer.
    Mo S; Pei Z; Dai L
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891
    [No Abstract]   [Full Text] [Related]  

  • 16. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
    Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
    Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
    Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
    Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.
    Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P
    Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternative splicing implicated in immunity and prognosis of colon adenocarcinoma.
    Wu Z; Chen H; Liang Y; Luo W; Deng F; Zeng F
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107075. PubMed ID: 33099068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
    Ma B; Ren C; Yin Y; Zhao S; Li J; Yang H
    Front Immunol; 2024; 15():1411132. PubMed ID: 38840928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.